FMOD and neoplasm: Thus, we confirmed that endostar combined with cisplatin treatment could significantly reduce the level of m6A methylation modification of FMOD, which in turn caused a significant reduction in the translation level of FMOD, ultimately leading to a reduction in the expression of related anti-angiogenic factors and thus exerting anti-tumor effects.